About AmacaThera
AmacaThera is a Healthcare company based in Toronto (Canada) founded in 2015. It operates as an injectable hydrogel platform developed for therapeutic medical applications. AmacaThera has raised $14.22 million across 3 funding rounds from investors including BDC, Viva BioInnovator and Lumira Ventures. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its competitors include Augmenix, Regentis Biomaterials, LifeSprout, Biosyntech and ECM Therapeutics and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
AmacaThera was founded in 2015 in Toronto, Canada, within the biotechnology sector. An injectable hydrogel platform is developed by the company for diverse medical uses, including the delivery of pharmacological agents to address multiple disease areas. Operations focus on therapeutic innovations, with a combination product created for managing post-operative pain. The platform supports applications in healthcare delivery across various indications.
- Headquarters Toronto, Canada
- SectorsHealthcare
- Phone•••• ••••
- Website amacathera.ca
- Social LinkedIn
- Total Equity Funding$14.22M (USD)
in 3 rounds
- Latest Funding Round$8.16M (USD), Series A
Feb 2021
- InvestorsBDC
& 9 more
Funding Insights of AmacaThera
AmacaThera has successfully raised a total of $14.22M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8.16 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.22M
- Total Rounds 3
- Last Round Series A — $8.16M
- First Round $2.46M
(Jan 2019)
- Investors Count 10
All 3 funding rounds of AmacaThera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $8.16M | Series A | – | Lumira Ventures | |
| Oct 2019 | $3.6M | Seed | – | Sprout BioVentures, Viva BioInnovator | |
| Jan 2019 | $2.46M | Seed | – | Sprout BioVentures, Viva BioInnovator |
10 investors in total: 10 institutional.
Investors in AmacaThera
AmacaThera has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include BDC, Viva BioInnovator and Lumira Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Lumira Ventures is engaged in life sciences venture capital investment. | – | lumiraventures.com | Toronto, Canada | |
Biotechnology startups are incubated and funded by Viva BioInnovator. | 2014 | vivabioinnovator.com | Shanghai, China | |
Online lottery results are provided for Hongkong players daily. | – | sproutbioventures.com | - | |
Inveready is recognized as a leading Spanish financial services firm. | 2008 | inveready.com | San Sebastián, Spain | |
- | – | crcapm.com | - | |
Seed-stage investments are made in women-led technology companies. | – | standupvc.com | Toronto, Canada | |
Healthcare sector investments are managed by MBX Capital. | – | mbxcapital.com | New York, United States | |
Early-stage technology startups are supported through investments by MaRS IAF. | – | marsiaf.com | Canada | |
- | – | gsvp.com | - | |
Commercial banking services for small and medium-sized enterprises are provided. | 1944 | bdc.ca | Montreal, Canada |
Investor details for AmacaThera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AmacaThera
2 people are tracked at AmacaThera (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Abhaya Khulbe | Chief Of Staff | Leadership |
Elaine Reguera | Senior Scientist | Team |
Complete people profiles for AmacaThera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AmacaThera
3 dated milestones of AmacaThera across 6 years, from founding to its latest funding, stage changes and deals.
- Founded AmacaThera is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Series A, of $8.2M.
Competitors of AmacaThera
AmacaThera has 9 listed competitors in our database, 9 of them funded. They include Augmenix, Regentis Biomaterials, LifeSprout, Biosyntech and ECM Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| augmenix.com | 2008 | Waltham, United States | $46.6M | 153 | Hydrogel spacers are provided for prostate cancer radiation therapy. | |
| regentis.co.il | 2004 | Or Akiva, Israel | $25M | – | Regentis Biomaterials is focused on tissue repair hydrogel technology. | |
| lifesproutbio.com | 2015 | Baltimore, United States | $44.7M | 12 | Synthetic soft tissue substitutes for cosmetics and reconstructive surgery | |
| biosyntech.com | 1994 | Laval, Canada | $1.4M | – | Biotherapeutic thermogels are developed for tissue repair applications. | |
| ecmtherapeutics.com | 2018 | Warrendale, United States | $26.1M | – | Diagnostic and therapeutic products from extracellular matrix are developed. | |
| carbylan.com | 2004 | Palo Alto, United States | $42.9M | 7 | Hyaluronic acid polymers are developed into therapeutics for pain management. | |
| lonestarheartinc.com | 2010 | Laguna Hills, United States | $45.18M | 2 | Develops cardiac therapies for patients with chronic heart failure. | |
| gelmedix.com | 2019 | Newton, United States | $7.84M | – | Hydrogel drug delivery technology for ophthalmic treatments is developed. | |
| glycosan.com | 2006 | Alameda, United States | $950,000 | – | Biocompatible hydrogels mimicking extracellular matrix are developed for tissue engineering. |
Detailed competitors of AmacaThera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as AmacaThera (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amacathera
Complete news archive for AmacaThera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmacaThera
AmacaThera was founded in 2015 and raised its 1st funding round 4 years after it was founded.
AmacaThera is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
AmacaThera is a funded company, having raised a total of $14.22M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.46M, raised on Jan 2019.
AmacaThera was founded in 2015 in Toronto, Canada, within the biotechnology sector. An injectable hydrogel platform is developed by the company for diverse medical uses, including the delivery of pharmacological agents to address multiple disease areas. Operations focus on therapeutic innovations, with a combination product created for managing post-operative pain. The platform supports applications in healthcare delivery across various indications.
AmacaThera's top competitors include Augmenix, LifeSprout and Regentis Biomaterials.
AmacaThera has 10 investors. Key investors include BDC, Viva BioInnovator, Lumira Ventures, HK Pools, and Inveready.